
Novartis stock jumps after drugmaker raises full-year guidance, launches $15 billion buyback
Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company made both announcements as it reported second-quarter earnings, which topped Wall Street’s expectations.The share buybacks will go to the end of 2025, Novartis said. The company, which is sitting on… […]